Bivatuzumab Biosimilar - Research Grade

Human

CD44ï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P15379;P16070;P15379;P16070;;P16070;P26051

Blue ice

CD44 is a hyaluronan receptor involved in cell adhesion, migration and stem-cell signaling, and it is widely studied in cancer and tissue-remodeling research. This product is an unconjugated, non-therapeutic analog of bivatuzumab, a human IgG1-kappa recombinant antibody for research use only. It is supplied as a low-endotoxin, in vivo-suitable formulation and produced in scalable milligram-to-gram quantities for bulk and high-throughput laboratories. Applications include functional and adhesion assays, internalization and migration studies, in vitro screening, ADC development work and preclinical tumor models exploring CD44 biology. The in vivo-suitable, low-endotoxin preparation is produced at milligram-to-gram scale to support sustained, high-throughput research programs.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks